Are you Dr. Martel-Laferriere?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 1 invite waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Gustave L Levy Pl
Mount Sinai School Of Medicine
New York, NY 10029Phone+1 646-260-0459- Is this information wrong?
Clinical Trials
- Accelerated Pre-treatment Evaluation for HCV Infected Persons Who Inject Drugs Start of enrollment: 2017 Jan 01
Publications & Presentations
PubMed
- 35 citationsCosts of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response.Kian Bichoupan, Valérie Martel-Laferrière, David H. Sachs, Michel Ng, Emily A. Schonfeld, Alexis Pappas, James F. Crismale, A. Stivala, Viktoriya Khaitova, Donald Gard...> ;Hepatology. 2014 Oct 1
- 5 citationsDiabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy.James F. Crismale, Valérie Martel-Laferrière, Kian Bichoupan, Emily A. Schonfeld, Alexis Pappas, Christina M. Wyatt, Joseph A. Odin, Lawrence U. Liu, Thomas D. Schiano...> ;Liver International. 2014 Aug 1
- 11 citationsHIV-hepatitis C virus co-infection in the era of direct-acting antivirals.Kian Bichoupan, Douglas T. Dieterich, Valérie Martel-Laferrière> ;Current HIV/AIDS Reports. 2014 Jul 5
- Join now to see all
